Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 1/20 | 0.42 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.42 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | CETP | P11597 | 4/20 | 0.34 |
| ▸ | CPB2 | Q96IY4 | 6/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | FAAH | O00519 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15125006 | 1.00 | CYP4F2 (0.42) | CYP4F2CYP4A11TBXAS1CYP2C19L3MBTL1 | |
| SCHEMBL11035397 | 1.00 | CYP4F2 (0.42) | CYP4F2CYP4A11TBXAS1CYP2C19L3MBTL1 | |
| SCHEMBL3961747 | 1.00 | CYP4F2 (0.42) | CYP4F2CYP4A11TBXAS1CYP2C19L3MBTL1 | |
| SCHEMBL15520905 | 1.00 | CYP4F2 (0.42) | CYP4F2CYP4A11TBXAS1CYP2C19L3MBTL1 | |
| SCHEMBL277732 | 1.00 | CYP4F2 (0.42) | CYP4F2CYP4A11TBXAS1CYP2C19L3MBTL1 | |
| SCHEMBL17870572 | 1.00 | CYP4F2 (0.42) | CYP4F2CYP4A11TBXAS1CYP2C19L3MBTL1 | |
| SCHEMBL10884457 | 1.00 | CYP4F2 (0.42) | CYP4F2CYP4A11TBXAS1CYP2C19L3MBTL1 | |
| SCHEMBL278023 | 1.00 | CYP4F2 (0.42) | CYP4F2CYP4A11TBXAS1CYP2C19L3MBTL1 | |
| SCHEMBL251232 | 1.00 | CYP4F2 (0.42) | CYP4F2CYP4A11TBXAS1CYP2C19L3MBTL1 | |
| SCHEMBL9989176 | 1.00 | CYP4F2 (0.42) | CYP4F2CYP4A11TBXAS1CYP2C19L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0904198-B1 | Three-layer Polyamide Film Structure | PLIANT CORP (US) | 2004-11-17 | — | — | EP | claimed |
| EP-0729490-B1 | POLYAMIDE COMPOSITIONS COMPRISING ALIPHATIC POLYAMIDE AND AN AROMATIC POLYAMIDE OLIGOMER HAVING IMPROVED MOISTURE RESISTANCE | ALLIED SIGNAL INC (US) | 1998-09-09 | — | — | EP | claimed |
| US-12043719-B2 | Flame retardant mixture | CLARIANT INTERNATIONAL LTD (CH) | 2024-07-23 | — | — | US | disclosed |
| EP-4367122-A1 | SUSTAINABLY PRODUCED DIALKYLPHOSPHINIC SALTS | Clariant International Ltd (CH) | 2024-05-15 | — | — | EP | disclosed |
| WO-2023280613-A1 | SUSTAINABLY PRODUCED DIALKYLPHOSPHINIC SALTS | CLARIANT INTERNATIONAL LTD (CH) | 2023-01-12 | — | — | WO | disclosed |
| EP-4116309-A1 | SUSTAINABLY PRODUCED DIALKYLPHOSPHINIC SALTS | Clariant International Ltd (CH) | 2023-01-11 | — | — | EP | disclosed |
| US-11312910-B2 | Diorganylphosphinic acid salts, method for the production thereof and the use thereof | CLARIANT INTERNATIONAL LTD (CH) | 2022-04-26 | — | — | US | disclosed |
| US-20220119625-A1 | FLAME RETARDANT MIXTURE | CLARIANT INTERNATIONAL LTD (CH) | 2022-04-21 | — | — | US | disclosed |
| EP-3911696-A1 | FLAME RETARDANT MIXTURE | Clariant International Ltd (CH) | 2021-11-24 | — | — | EP | disclosed |
| US-11028324-B2 | Flame retardant mixtures, the production and the use thereof | CLARIANT PLASTICS & COATINGS LTD (CH) | 2021-06-08 | — | — | US | disclosed |
| WO-2020147943-A1 | FLAME RETARDANT MIXTURE | CLARIANT PLASTICS & COATINGS LTD (CH) | 2020-07-23 | — | — | WO | disclosed |
| US-20070224421-A1 | Phosphorus-containing mixtures, a process for their preparation and their use | CLARIANT INTERNATIONAL LTD | 2007-09-27 | — | — | US | disclosed |
| US-20070221893-A1 | thermosetting; fireproofing | CLARIANT INTERNATIONAL LTD. | 2007-09-27 | — | — | US | disclosed |
| US-20070213563-A1 | Mixtures composed of monocarboxy-functionalized dialkylphosphinic acid salts, their use und a process for their preparation | CLARIANT INTERNATIONAL LTD | 2007-09-13 | — | — | US | disclosed |
| US-20070213436-A1 | Mixtures composed or monocarboxy-functionalized dialkylphosphinic acids, their use and a process for their preparation | CLARIANT INTERNATIONAL LTD | 2007-09-13 | — | — | US | disclosed |
| US-20070210288-A1 | Mixtures composed of monocarboxy-functionalized dialkylphosphinic esters and of further components | CLARIANT INTERNATIONAL LTD | 2007-09-13 | — | — | US | disclosed |
| US-20060084734-A1 | Dialkylphosphinic salts, their use, and a process for their preparation | CLARIANT GMBH | 2006-04-20 | — | — | US | disclosed |
| US-20060074157-A1 | Including the telomers: ethylbutylphospinic salts, butylbutylphosphinic salts, ethylhexylphosphinic salts, butylhexylphosphinic salts, or hexylhexylphosphinic salts; flame-retardant polymer molding materials | CLARIANT GMBH | 2006-04-06 | — | — | US | disclosed |
| US-20060020064-A1 | Flame-retardant polymer molding compositions | CLARIANT GMBH | 2006-01-26 | — | — | US | disclosed |
| US-5410015-A | Adding a phenolic compound such as tri(p-hydroxyphenyl)methane | BASF AKTIENGESELLSCHAFT (DE) | 1995-04-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070213563-A1 | Mixtures composed of monocarboxy-functionalized dialkylphosphinic acid salts, their use und a process for their preparation | DBH, HBB, ALKBH3 | CYP4F2 2176/4885CYP4A11 762/4885TBXAS1 2256/4885 |
| US-11312910-B2 | Diorganylphosphinic acid salts, method for the production thereof and the use thereof | PPIP5K2, DCPS, FDPS | CYP4F2 426/4885CYP4A11 823/4885TBXAS1 2485/4885 |
| US-20070213436-A1 | Mixtures composed or monocarboxy-functionalized dialkylphosphinic acids, their use and a process for their preparation | PAH, ALKBH3, FTO | CYP4F2 397/4885CYP4A11 448/4885TBXAS1 2849/4885 |
| US-20070210288-A1 | Mixtures composed of monocarboxy-functionalized dialkylphosphinic esters and of further components | ALKBH3, FFAR3, EBP | CYP4F2 706/4885CYP4A11 573/4885TBXAS1 2637/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.